<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01900067</url>
  </required_header>
  <id_info>
    <org_study_id>MD12-001</org_study_id>
    <nct_id>NCT01900067</nct_id>
  </id_info>
  <brief_title>Study to Evaluate Safety and Efficacy of Blanket Used to Prevent Anesthesia Induced Hypothermia</brief_title>
  <official_title>An Open-Label, Multicenter, Randomised, Controlled Study to Evaluate the Efficacy and Safety of the BARRIER® EasyWarm Active Self-Warming Blanket Used for Continuous Active Warming to Prevent General Anaesthesia Induced Hypothermia During the Perioperative Surgical Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Molnlycke Health Care AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Molnlycke Health Care AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigation was designed as an Open-Label, Multicenter, Randomised, Controlled
      Investigation to Evaluate the Efficacy and Safety of the BARRIER® EasyWarm Active
      Self-Warming Blanket Used for Continuous Active Warming to Prevent General Anaesthesia
      Induced Hypothermia During the Perioperative Surgical Period. Null hypothesis (H0): There is
      no difference between the two study populations (interventional treatment group versus
      control treatment group) regarding the average of core body temperature measurements during
      the perioperative phase.Alternative hypothesis (H1): The average of core body temperature
      measurements during the perioperative phase is significantly higher in the interventional
      group compared to that of the control group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Difference in the Arithmetic Mean of Core Body Temperature Measurements During the Perioperative Phase Between the Interventional Treatment Group and the Control Treatment Group</measure>
    <time_frame>temperature measurments during pre,-intra and postoperative period, on average 1-5 hours, depending on the surgical intervention.</time_frame>
    <description>The subject's core body temperature at any time point is approximated by the arithmetic mean of three repeated tympanic temperature measurements every 15 minutes during the perioperative period</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">271</enrollment>
  <condition>Anesthesia Induced Hypothermia</condition>
  <condition>Inadvertent Perioperative Hypothermia</condition>
  <arm_group>
    <arm_group_label>Active warming</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>BARRIER® EasyWarm Active Self-Warming Blanket</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no active warming, standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BARRIER® EasyWarm Active Self-Warming Blanket</intervention_name>
    <arm_group_label>Active warming</arm_group_label>
    <other_name>active warming</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Gender: Both men and women are included into the study

          2. Subjects' age: Subjects must be at least 18 years old to be included into the study

          3. Type of anaesthesia: Only subjects receiving general anaesthesia are included into the
             study

          4. Type of surgery: Subjects undergoing only the following three types of surgical
             procedures (i.e. inclusive of laparoscopic procedures) are included into the study:

               -  Gynaecological

               -  Orthopaedic

               -  Ear, nose and throat (ENT)

          5. Length of surgery: Subjects scheduled for a surgery with a minimum length of 30
             minutes and maximum length of 120 minutes

          6. Temperature: Subjects should have a tympanic temperature measurement equal to or
             greater than 36.0 degrees Celsius when first measured in the preoperative setting the
             same day as the surgical procedure and before randomisation

          7. Informed Consent Form (ICF): The subject must be able to understand and sign an ICF

          8. Method of temperature assessment: The subject must be able to receive temperature
             assessments via a tympanic thermometer

          9. Preoperative warming: Subject's scheduled surgical procedure must allow time to be
             warmed with a fully activated study Investigational Device (ID), at least 30 minutes
             prior to induction of general anaesthesia

         10. Follow up: The subject must be able to complete a health outcomes questionnaire for
             follow up 24 hours (+/- 6 hours) after removal of the ID

        Exclusion Criteria:

          1. American Society of Anesthesiologists (ASA) Physical Status Classification rating:
             Subjects with a ASA rating of 4 or greater are excluded from the study

          2. Comorbidity: Known Diabetes with an HbA1c of more than 6 %

          3. Temperature: Subjects with a tympanic temperature measurement below 36.0 degrees
             Celsius taken in the preoperative setting

          4. Medical history: Subject reports relevant medical history (e.g., neuropathy,
             peripheral vascular disease, or other) that presents risk to/of:

               1. The subject's normal temperature regulation or

               2. Perception of external temperature or

               3. Subcutaneous lipoatrophy

          5. Medication: Current use of concomitant medications that present relevant risk to/of:

               1. The subject's normal temperature regulation or

               2. Perception of external temperature or Clinical Investigation Plan with Integrated
                  Amendments 01 and 02, MD12-001, final, 14-Jan-2013 5(32)

               3. Subcutaneous lipoatrophy or

               4. All locoregional and neuroaxial blocks

          6. Other:

               1. Presence of skin and soft tissue disorders in areas covered directly by the ID
                  (e.g., pressure ulcers, clinically significant psoriasis, dermatitis or any other
                  interruption of skin integrity that would be affected by direct heat)

               2. Known pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Torossian, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Gießen und Marburg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johan Raeder, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>OUS-Ullevål</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karin Geertsen, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hallands sjukhus Varberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bengt Horn af Åminne, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aleris Specialistvård, Motala</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elke Van Gerven, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven Gasthuisberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Van de Velde, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>UZ Leuven Gasthuisberg</affiliation>
  </overall_official>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2013</study_first_submitted>
  <study_first_submitted_qc>July 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2013</study_first_posted>
  <results_first_submitted>December 10, 2014</results_first_submitted>
  <results_first_submitted_qc>April 21, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 6, 2015</results_first_posted>
  <last_update_submitted>April 21, 2015</last_update_submitted>
  <last_update_submitted_qc>April 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypothermia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Active Warming</title>
          <description>BARRIER® EasyWarm Active Self-Warming Blanket
BARRIER® EasyWarm Active Self-Warming Blanket</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>no active warming, standard of care</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="134"/>
                <participants group_id="P2" count="137"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="122"/>
                <participants group_id="P2" count="124"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Active Warming</title>
          <description>BARRIER® EasyWarm Active Self-Warming Blanket</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>no active warming, standard of care</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="122"/>
            <count group_id="B2" value="124"/>
            <count group_id="B3" value="246"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.5" spread="15.3"/>
                    <measurement group_id="B2" value="45.6" spread="14.8"/>
                    <measurement group_id="B3" value="46.1" spread="15.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="92"/>
                    <measurement group_id="B2" value="96"/>
                    <measurement group_id="B3" value="188"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Difference in the Arithmetic Mean of Core Body Temperature Measurements During the Perioperative Phase Between the Interventional Treatment Group and the Control Treatment Group</title>
        <description>The subject's core body temperature at any time point is approximated by the arithmetic mean of three repeated tympanic temperature measurements every 15 minutes during the perioperative period</description>
        <time_frame>temperature measurments during pre,-intra and postoperative period, on average 1-5 hours, depending on the surgical intervention.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active Warming</title>
            <description>BARRIER® EasyWarm Active Self-Warming Blanket</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No active warming, standard of care</description>
          </group>
        </group_list>
        <measure>
          <title>The Difference in the Arithmetic Mean of Core Body Temperature Measurements During the Perioperative Phase Between the Interventional Treatment Group and the Control Treatment Group</title>
          <description>The subject's core body temperature at any time point is approximated by the arithmetic mean of three repeated tympanic temperature measurements every 15 minutes during the perioperative period</description>
          <units>Degree Celsius (°C)</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="122"/>
                <count group_id="O2" value="124"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.52" lower_limit="36.15" upper_limit="36.89"/>
                    <measurement group_id="O2" value="36.34" lower_limit="36.0" upper_limit="36.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Active Warming</title>
          <description>BARRIER® EasyWarm Active Self-Warming Blanket</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>No active warming, standard of care</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="134"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="137"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="134"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="137"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Redness of skin</sub_title>
                <description>All adverse device effects were of the type redness of skin under one or more of the warmers of the device. Once the device was removed the redness vanished quickly without further treatment. Redness was judged to be caused by local vasodilatation.</description>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="134"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="137"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The agreement state that sponsor is the owner of all results. The Investigator may perform a secondary publication from an individual investigation site without disclosing confidential information received from sponsor after the multi-center publication or within 12 months after termination of the investigation if no such multi-centre publication takes place.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jenny Höglind</name_or_title>
      <organization>Mölnlycke Health Care AB, Surgical Division</organization>
      <phone>0046 31 722 30 00</phone>
      <email>Jenny.Hoglind@molnlycke.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

